WO2007009800A3 - Nicht-ausspuckbarer, oraler, schnell-zerfallender film für antiemetikum oder antimigränemittel - Google Patents

Nicht-ausspuckbarer, oraler, schnell-zerfallender film für antiemetikum oder antimigränemittel Download PDF

Info

Publication number
WO2007009800A3
WO2007009800A3 PCT/EP2006/007176 EP2006007176W WO2007009800A3 WO 2007009800 A3 WO2007009800 A3 WO 2007009800A3 EP 2006007176 W EP2006007176 W EP 2006007176W WO 2007009800 A3 WO2007009800 A3 WO 2007009800A3
Authority
WO
WIPO (PCT)
Prior art keywords
antiemetic
oral
spit out
disintegrating film
quickly disintegrating
Prior art date
Application number
PCT/EP2006/007176
Other languages
German (de)
English (en)
French (fr)
Other versions
WO2007009800A2 (de
Inventor
Petra Obermeier
Thomas Kohr
Kai-Thomas Kramer
Karin Klokkers
Original Assignee
Hexal Ag
Petra Obermeier
Thomas Kohr
Kai-Thomas Kramer
Karin Klokkers
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hexal Ag, Petra Obermeier, Thomas Kohr, Kai-Thomas Kramer, Karin Klokkers filed Critical Hexal Ag
Priority to MX2008000848A priority Critical patent/MX2008000848A/es
Priority to EP06776332A priority patent/EP1906917A2/de
Priority to AU2006271864A priority patent/AU2006271864A1/en
Priority to JP2008521901A priority patent/JP2009501751A/ja
Priority to BRPI0613871-3A priority patent/BRPI0613871A2/pt
Priority to CA002615552A priority patent/CA2615552A1/en
Priority to US11/996,371 priority patent/US20080213343A1/en
Publication of WO2007009800A2 publication Critical patent/WO2007009800A2/de
Publication of WO2007009800A3 publication Critical patent/WO2007009800A3/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
PCT/EP2006/007176 2005-07-20 2006-07-20 Nicht-ausspuckbarer, oraler, schnell-zerfallender film für antiemetikum oder antimigränemittel WO2007009800A2 (de)

Priority Applications (7)

Application Number Priority Date Filing Date Title
MX2008000848A MX2008000848A (es) 2005-07-20 2006-07-20 Pelicula oral de rapida desintegracion, imposible de escupir, para un antiemetico o un medicamento contra la migrana.
EP06776332A EP1906917A2 (de) 2005-07-20 2006-07-20 Nicht-ausspuckbarer, oraler, schnell-zerfallender film für antiemetikum oder antimigränemittel
AU2006271864A AU2006271864A1 (en) 2005-07-20 2006-07-20 Oral, quickly disintegrating film, which cannot be spit out, for an antiemetic or antimigraine agent
JP2008521901A JP2009501751A (ja) 2005-07-20 2006-07-20 制吐薬又は抗片頭痛剤用の、吐き出すことができない経口用迅速崩壊性フィルム
BRPI0613871-3A BRPI0613871A2 (pt) 2005-07-20 2006-07-20 preparação em forma de filme para agentes antieméticos ou antienxaqueca, processo para produção da mesma, recipiente de doses múltiplas, bolsa sache, composição e uso da mesma
CA002615552A CA2615552A1 (en) 2005-07-20 2006-07-20 Oral, quickly disintegrating film, which cannot be spit out, for an antiemetic or antimigraine agent
US11/996,371 US20080213343A1 (en) 2005-07-20 2006-07-20 Oral, Quickly Disintegrating Film, which Cannot be Spit Out, for an Antiemetic or Antimigraine Agent

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005033942A DE102005033942A1 (de) 2005-07-20 2005-07-20 Nicht-ausspuckbarer, oraler, schnell-zerfallender Film für Antiemetikum oder Antimigränemittel
DE102005033942.5 2005-07-20

Publications (2)

Publication Number Publication Date
WO2007009800A2 WO2007009800A2 (de) 2007-01-25
WO2007009800A3 true WO2007009800A3 (de) 2007-06-28

Family

ID=37156007

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2006/007176 WO2007009800A2 (de) 2005-07-20 2006-07-20 Nicht-ausspuckbarer, oraler, schnell-zerfallender film für antiemetikum oder antimigränemittel

Country Status (12)

Country Link
US (1) US20080213343A1 (en15)
EP (1) EP1906917A2 (en15)
JP (1) JP2009501751A (en15)
CN (1) CN101287444A (en15)
AU (1) AU2006271864A1 (en15)
BR (1) BRPI0613871A2 (en15)
CA (1) CA2615552A1 (en15)
DE (1) DE102005033942A1 (en15)
MX (1) MX2008000848A (en15)
RU (1) RU2008105825A (en15)
WO (1) WO2007009800A2 (en15)
ZA (1) ZA200800975B (en15)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8580830B2 (en) 2006-10-02 2013-11-12 Labtec Gmbh Non-mucoadhesive film dosage forms
CA2665841C (en) 2006-10-09 2016-04-05 Charleston Laboratories, Inc. Pharmaceutical compositions
US20090148393A1 (en) * 2007-12-11 2009-06-11 Avon Products, Inc. Multistep Cosmetic Compositions
JP5714910B2 (ja) 2008-01-09 2015-05-07 チャールストン ラボラトリーズ，インコーポレイテッド 薬学的組成物
US8715715B2 (en) * 2008-11-03 2014-05-06 Nal Pharmaceuticals Ltd. Dosage form for insertion into the mouth
US20100297232A1 (en) * 2009-05-19 2010-11-25 Monosol Rx, Llc Ondansetron film compositions
CN101849925B (zh) * 2009-06-12 2012-04-18 上海现代药物制剂工程研究中心有限公司 苯甲酸利扎曲普坦膜剂
CA2767576C (en) 2009-07-08 2020-03-10 Charleston Laboratories Inc. Pharmaceutical compositions comprising an antiemetic and an opioid analgesic
CN102048711B (zh) * 2009-11-11 2013-06-05 河北奥星集团药业有限公司 一种格拉司琼膜制剂及其制备方法
RU2560693C2 (ru) * 2010-03-23 2015-08-20 Апр Эпплайд Фарма Рисерч, С.А. Быстро растворяющиеся системы, освобождающие лекарственные препараты
EP2566467A1 (de) 2010-05-07 2013-03-13 Hexal Aktiengesellschaft Mucosaler film enthaltend zwei zuckeraustauschstoffe
DE102010049706A1 (de) 2010-10-28 2012-05-03 Hexal Ag Herstellung orodispersibler Filme
DE102010049708A1 (de) 2010-10-28 2012-05-03 Hexal Ag Orale pharmazeutische Filmformulierung für bitter schmeckende Arzneistoffe
WO2013084590A1 (ja) * 2011-12-09 2013-06-13 Dic株式会社 造膜助剤ならびにそれを含有する水性樹脂組成物及び鋼板表面処理剤
ITMI20121628A1 (it) * 2012-09-28 2014-03-29 Pharmafilm Srl Film orodisperdibili autosupportanti a rapida dissoluzione per uso terapeutico o alimentare
US10413516B2 (en) 2013-05-09 2019-09-17 Cure Pharmaceutical Corporation Thin film with high load of active ingredient
AU2015289150B2 (en) 2014-07-17 2020-10-15 Hexal Ag Orodispersible film
US10226450B2 (en) 2014-09-25 2019-03-12 Shilpa Medicare Limited Pharmaceutical film composition
US10179109B2 (en) 2016-03-04 2019-01-15 Charleston Laboratories, Inc. Pharmaceutical compositions comprising 5HT receptor agonist and antiemetic particulates
DE102017103346A1 (de) 2017-02-17 2018-08-23 Lts Lohmann Therapie-Systeme Ag Strukturierte orodispergierbare Filme
WO2020010454A1 (en) * 2018-07-10 2020-01-16 Beleave Inc. Formulation of cannabinoid compounds
US11672761B2 (en) 2020-11-16 2023-06-13 Orcosa Inc. Rapidly infusing platform and compositions for therapeutic treatment in humans

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0232877A2 (en) * 1986-02-10 1987-08-19 Zetachron, Inc. Buccal drug dosage form
WO2003003957A1 (en) * 2001-07-06 2003-01-16 Lavipharm Laboratories Inc. Quick dissolving oral mucosal drug delivery device with moisture barrier coating
US20030194420A1 (en) * 2002-04-11 2003-10-16 Richard Holl Process for loading a drug delivery device
WO2004012720A1 (en) * 2002-07-26 2004-02-12 Pfizer Limited Process for making orally consumable dosage forms
WO2005016321A1 (en) * 2003-08-15 2005-02-24 Qlt Usa, Inc. Adhesive bioerodible transmucosal drug delivery system
WO2005031675A1 (en) * 2003-09-30 2005-04-07 Koninklijke Philips Electronics, N.V. Universal remote controller with appliance identification

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040247649A1 (en) * 2002-02-11 2004-12-09 Edizone, Lc Medicine-containing orally soluble films

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0232877A2 (en) * 1986-02-10 1987-08-19 Zetachron, Inc. Buccal drug dosage form
WO2003003957A1 (en) * 2001-07-06 2003-01-16 Lavipharm Laboratories Inc. Quick dissolving oral mucosal drug delivery device with moisture barrier coating
US20030194420A1 (en) * 2002-04-11 2003-10-16 Richard Holl Process for loading a drug delivery device
WO2004012720A1 (en) * 2002-07-26 2004-02-12 Pfizer Limited Process for making orally consumable dosage forms
WO2005016321A1 (en) * 2003-08-15 2005-02-24 Qlt Usa, Inc. Adhesive bioerodible transmucosal drug delivery system
WO2005031675A1 (en) * 2003-09-30 2005-04-07 Koninklijke Philips Electronics, N.V. Universal remote controller with appliance identification

Also Published As

Publication number Publication date
MX2008000848A (es) 2008-03-26
AU2006271864A1 (en) 2007-01-25
BRPI0613871A2 (pt) 2011-02-15
RU2008105825A (ru) 2009-10-20
ZA200800975B (en) 2009-08-26
EP1906917A2 (de) 2008-04-09
CN101287444A (zh) 2008-10-15
US20080213343A1 (en) 2008-09-04
JP2009501751A (ja) 2009-01-22
WO2007009800A2 (de) 2007-01-25
CA2615552A1 (en) 2007-01-25
DE102005033942A1 (de) 2007-02-22

Similar Documents

Publication Publication Date Title
WO2007009800A3 (de) Nicht-ausspuckbarer, oraler, schnell-zerfallender film für antiemetikum oder antimigränemittel
WO2007009801A3 (de) Nicht-ausspuckbarer, oraler, schnell-zerfallender film für ein neuroleptikum
WO2007045252A3 (en) An edible composition
WO2007070504A3 (en) Stable and palatable oral liquid sumatriptan compositions
WO2006087227A3 (de) Wirkstoffzusammensetzung die wenigstens ein stickstoffatomhaltiges hyperverweigtes polymer enthält
WO2006138418A3 (en) Improvement of cognitive performance with sirtuin activators
WO2007002597A3 (en) Modified-release formulations of a bupropion salt
WO2010019587A8 (en) Oral care composition comprising capsules
WO2005070183A3 (en) Ice cream and ice cream formulations containing maltitol
WO2005034650A8 (en) Weight-loss supplement
WO2007059953A8 (de) Präparat enthaltend eine polyphenolhaltige zusammensetzung und isomaltulose
WO2005055973A3 (de) Endoparasitizide mittel zur topischen applikation
WO2010033726A3 (en) Drug delivery composition comprising a self-assembled gelator
WO2007016352A3 (en) Oral liquid losartan compositions
WO2006056696A3 (fr) 2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation
WO2005074925A8 (en) Compositions substantially free of galactomannan containing piperacillin and tazobactam
GB2443793B (en) Product, method of manufacture and use
WO2008132021A3 (de) Fungizide mischungen
WO2007003264A3 (de) Polyasparaginsäurederivate in polysiloxan-haltigen beschichtungsmitteln
WO2009038095A1 (ja) セサミン類とビタミンｂ１類とを配合した組成物
WO2008003050A3 (en) Gallium nitrate formulations
WO2004073686A3 (en) Menthol solutions of drugs
WO2007028978A3 (en) Ramipril formulation
WO2007098924A3 (de) Zusammensetzung umfassend ein mittel zum stabilisieren von wirkstoffen im trinkwasser und eine brausemischung, verfahren zu deren herstellung und deren verwendung
DE69813846T2 (de) Geschmacksmaskierung schlecht schmeckender formulierungen

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200680034500.0

Country of ref document: CN

DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2615552

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: MX/a/2008/000848

Country of ref document: MX

Ref document number: 2008521901

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 312/CHENP/2008

Country of ref document: IN

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Ref document number: DE

WWE Wipo information: entry into national phase

Ref document number: 2006271864

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2006776332

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2008105825

Country of ref document: RU

ENP Entry into the national phase

Ref document number: 2006271864

Country of ref document: AU

Date of ref document: 20060720

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2006271864

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 11996371

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2006776332

Country of ref document: EP

ENP Entry into the national phase

Ref document number: PI0613871

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20080121